Virtu Financial’s GeneDx Holdings Warrant WGSWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23,262
Closed -$1K 2373
2025
Q4
$1K Buy
23,262
+11,670
+101% +$815 ﹤0.01% 1578
2025
Q3
$1K Buy
+11,592
New +$957 ﹤0.01% 1402
2025
Q1
Sell
-11,678
Closed -$2K 2104
2024
Q4
$2K Buy
+11,678
New +$2.01K ﹤0.01% 1454
2024
Q3
Sell
-35,185
Closed -$1K 1941
2024
Q2
$1K Sell
35,185
-21,311
-38% -$727 ﹤0.01% 1219
2024
Q1
$3K Buy
+56,496
New +$2.22K ﹤0.01% 1314
2023
Q1
Sell
-22,689
Closed 2152
2022
Q4
$0 Buy
+22,689
New +$2.34K ﹤0.01% 2190

Other funds holding WGSWW

Virtu Financial's WGSWW Position: Q1 2026 in Review

Virtu Financial sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2026, closing a stake of 23,262 shares — an estimated $1K sold.

Virtu Financial first reported a position in WGSWW in Q4 2022 and held it in 6 quarters. The position peaked at $3K in Q1 2024. 13 funds tracked by Wall St. Rank hold WGSWW as of Q1 2026.

  • Virtu Financial reported no remaining GeneDx Holdings Warrant position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 23,262 GeneDx Holdings Warrant shares in Q1 2026, an estimated $1K.
  • Virtu Financial first reported a position in GeneDx Holdings Warrant in Q4 2022 and held it in 6 quarters.
  • Virtu Financial's GeneDx Holdings Warrant position peaked at $3K in Q1 2024.
  • 13 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.